Accord Healthcare Ltd, Carmustine 100 mg powder and solvent for concentrate for solution for infusion (1 vial 100mg powder, 1 vial of 3 mL solvent)
Class 2 medicines recall: The MHRA has published a Class 2 medicines recall for Carmustine 100 mg powder and solvent for concentrate for solution for infusion (1 vial 100mg powder, 1 vial of 3 mL solvent).
Published: 2 February 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for Carmustine 100 mg powder and solvent for concentrate for solution for infusion (1 vial 100mg powder, 1 vial of 3 mL solvent). Accord Healthcare Limited is recalling a single batch due to an out of specification test result.
Pharmacists are advised to stop supplying the specific batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.
Further information, advice and details of the affected batch can be found on the MHRA website.